The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Ho Peter Tai-ching since 2014.
The trader's CIK number is 1619052.
At the time of the last reporting, Ho Peter Tai-ching was the Chief Development Officer of Epizyme, Inc.. (stock ticker symbol EPZM).
Also see all insider trading activities at Epizyme, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | EPZM | 0 | $0 | 90,000 | $1,400,265 | 90,000 | $808,200 |
| 2016 | EPZM | 0 | $0 | 200 | $2,178 | 0 | $0 |
| 2015 | EPZM | 4,322 | $69,668 | 0 | $0 | 0 | $0 |
| 2014 | EPZM | 1,400 | $28,224 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-10-24 | EPZM | Option Ex | 15,000 | 8.98 | 134,700 |
| 2017-10-24 | EPZM | Sale | 15,000 | 16.44 | 246,585 |
| 2017-09-25 | EPZM | Option Ex | 15,000 | 8.98 | 134,700 |
| 2017-09-25 | EPZM | Sale | 15,000 | 16.80 | 252,075 |
| 2017-08-24 | EPZM | Option Ex | 15,000 | 8.98 | 134,700 |
| 2017-08-24 | EPZM | Sale | 15,000 | 15.68 | 235,260 |
| 2017-07-24 | EPZM | Option Ex | 15,000 | 8.98 | 134,700 |
| 2017-07-24 | EPZM | Sale | 15,000 | 13.44 | 201,570 |
| 2017-06-26 | EPZM | Option Ex | 15,000 | 8.98 | 134,700 |
| 2017-06-26 | EPZM | Sale | 15,000 | 14.87 | 223,110 |
| 2017-05-25 | EPZM | Option Ex | 15,000 | 8.98 | 134,700 |
| 2017-05-25 | EPZM | Sale | 15,000 | 16.11 | 241,665 |
| 2016-12-08 | EPZM | Sale | 200 | 10.89 | 2,178 |
| 2015-12-09 | EPZM | Buy | 1,000 | 14.69 | 14,690 |
| 2015-08-31 | EPZM | Buy | 522 | 17.00 | 8,874 |
| 2015-08-20 | EPZM | Buy | 2,000 | 16.51 | 33,020 |
| 2015-05-05 | EPZM | Buy | 800 | 16.36 | 13,084 |
| 2014-12-16 | EPZM | Buy | 400 | 17.63 | 7,052 |
| 2014-12-02 | EPZM | Buy | 1,000 | 21.17 | 21,172 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Ho Peter Tai-ching (Chief Development Officer of Epizyme, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.